Colgate-Palmolive (CL) Beats Q1 2026 on Revenue and EPS as Shares Gain

Colgate-Palmolive Company (NYSE: CL) delivered a broad-based beat in Q1 2026, reporting adjusted EPS of $0.97 against the consensus estimate of $0.94 — a 2.7% positive surprise — while revenue of $5.32 billion came in ahead of the $5.22 billion estimate. Shares responded positively, rising 1.03% to $85.36 on the session.

Q1 2026 At a Glance

• Revenue: $5.32B, up 8.4% year-over-year vs. estimate of $5.22B
• Adjusted EPS: $0.97 vs. consensus of $0.94 — beat of $0.03
• Gross margin: 60.1%, reflecting strong product-level profitability
• Operating margin: 20.4%, indicating disciplined cost control at the operating level
• Net margin: 10.5% on a trailing basis
• Market cap: $68.5B | Trailing P/E: 32.5x | Forward P/E: 21.0x
• 52-week range: $74.55 – $99.33; current price sits at $85.36

What Drove the Results

The quarter's outperformance was attributed to broad-based growth across the business, with revenue expanding 8.4% year-over-year to $5.32 billion. The result suggests that volume and pricing dynamics remained constructive even against a challenging macroeconomic backdrop for consumer goods companies.

On the profitability side, a gross margin of 60.1% and an operating margin of 20.4% point to effective cost management. Analyst commentary heading into the print had flagged the potential for margin improvement from easing input costs, and the Q1 figures appear consistent with that thesis. The notable compression between the trailing P/E of 32.5x and the forward P/E of 21.0x suggests the market is pricing in meaningful near-term profit improvement.

Wall Street View

Analyst sentiment heading into the result was constructive, and the consensus has held steady. As of April 1, 2026, the breakdown stands at 5 Strong Buy, 14 Buy, 10 Hold, 0 Sell, and 1 Strong Sell — an unchanged distribution from the prior month's March 1 reading. The absence of any downward ratings drift in recent months reflects confidence in the company's execution, though the 10 Hold ratings indicate a segment of the Street remains watchful on valuation at current levels.

Investor Takeaway

Colgate-Palmolive (NYSE: CL) demonstrated that its consumer staples franchise continues to generate consistent top- and bottom-line results, with Q1 2026 revenue growth of 8.4% and an EPS beat of 2.7% above consensus. The forward P/E of 21.0x versus the trailing multiple of 32.5x implies that analysts expect a meaningful step-up in profitability over the next twelve months, a view broadly supported by the current Buy-leaning Wall Street consensus. Investors will likely focus on whether the company can sustain these margins as the year progresses, particularly given the current macroeconomic uncertainty facing the broader consumer sector.